Biomarker discovery offers hope for aggressive breast cancer treatment

A new study led by Lund University in Sweden has solved a years-old mystery: which patients with aggressive breast cancer are helped by a targeted cancer treatment that had been under development but was shelved.

Regeneron’s EYLEA HD injection received FDA approval

EYLEA HD is indicated for the treatment of wet age-related macular degeneration. Credit: Image Point Fr/Shutterstock.com. The US Food and Drug Administration (FDA) has granted

August 21, 2023

U.S. appeals court strikes down key provisions in Oklahoma law that regulates PBMs

A U.S. appeals court struck down key parts of an Oklahoma law designed to regulate the retail networks created by pharmacy benefit managers, dealing a

August 17, 2023

Breakthrough study sheds light on mechanisms behind the spread of gastric cancer to the peritoneum

Gastric cancer remains a formidable adversary, ranking as the fifth most common cancer and the third-leading cause of cancer-related deaths worldwide, with over 1,000,000 new

September 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.